CoChat
Sign Up
Cited by 142

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction

Alogna, Alessio, Koepp, Katlyn E., Sabbah, Michael, Espindola Netto, Jair M., Jensen, Michael D., Kirkland, James L., Lam, Carolyn S.P., Obokata, Masaru, Petrie, Mark C., Ridker, Paul M., Sorimachi, Hidemi, Tchkonia, Tamara, Voors, Adriaan, Redfield, Margaret M., Borlaug, Barry A.·2023·JACC: Heart Failure
DOI 10.1016/j.jchf.2023.06.031PMC PMC10895473
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2023.06.031

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. Murphy, 2020, Inflammation in heart failure: JACC State-of-the-Art Review, J Am Coll Cardiol, 75, 1324, 10.1016/j.jacc.2020.01.014 · DOI
  2. Schiattarella, 2021, Metabolic inflammation in heart failure with preserved ejection fraction, Cardiovasc Res, 117, 423, 10.1093/cvr/cvaa217 · DOI · Paper page
  3. Adamo, 2020, Reappraising the role of inflammation in heart failure, Nat Rev Cardiol, 17, 269, 10.1038/s41569-019-0315-x · DOI
  4. Sanders-van Wijk, 2020, Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF Study, Circulation, 142, 2029, 10.1161/CIRCULATIONAHA.120.045810 · DOI
  5. Markousis-Mavrogenis, 2019, The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study, Eur J Heart Fail, 21, 965, 10.1002/ejhf.1482 · DOI
  6. Ridker, 2021, Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease, Circ Res, 128, 1728, 10.1161/CIRCRESAHA.121.319077 · DOI
  7. Kalogeropoulos, 2010, Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study, J Am Coll Cardiol, 55, 2129, 10.1016/j.jacc.2009.12.045 · DOI · Paper page
  8. Chia, 2021, Interleukin 6 and development of heart failure with preserved ejection fraction in the general population, J Am Heart Assoc, 10
  9. Hanberg, 2018, Inflammation and cardio-renal interactions in heart failure: a potential role for interleukin-6, Eur J Heart Fail, 20, 933, 10.1002/ejhf.963 · DOI
  10. Obokata, 2017, Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction, Circulation, 136, 6, 10.1161/CIRCULATIONAHA.116.026807 · DOI · Paper page
  11. Reddy, 2019, Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study, Mayo Clin Proc, 94, 1199, 10.1016/j.mayocp.2018.11.037 · DOI · Paper page
  12. Sabbah, 2020, Obese-inflammatory phenotypes in heart failure with preserved ejection fraction, Circ Heart Fail, 13, 10.1161/CIRCHEARTFAILURE.119.006414 · DOI
  13. Sorimachi, 2021, Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction, Eur Heart J, 42, 1595, 10.1093/eurheartj/ehaa823 · DOI · Paper page
  14. Sorimachi, 2022, Sex and central obesity in heart failure with preserved ejection fraction, Eur J Heart Fail, 24, 1359, 10.1002/ejhf.2563 · DOI
  15. Everett, 2019, Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure, Circulation, 139, 1289, 10.1161/CIRCULATIONAHA.118.038010 · DOI · Paper page
  16. Redfield, 2013, Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial, JAMA, 309, 1268, 10.1001/jama.2013.2024 · DOI
  17. Redfield, 2015, Isosorbide mononitrate in heart failure with preserved ejection fraction, N Engl J Med, 373, 2314, 10.1056/NEJMoa1510774 · DOI
  18. Borlaug, 2018, Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial, JAMA, 320, 1764, 10.1001/jama.2018.14852 · DOI
  19. Pieske, 2019, How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), Eur Heart J, 40, 3297, 10.1093/eurheartj/ehz641 · DOI
  20. Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 28, 1, 10.1016/j.echo.2014.10.003 · DOI · Paper page
  21. Schott, 2022, Association of arterial stiffness and heart failure with preserved ejection fraction in the elderly population - results from the CARLA study, J Hum Hypertens, 37, 463, 10.1038/s41371-022-00703-y · DOI
  22. Weir, 1949, New methods for calculating metabolic rate with special reference to protein metabolism, J Physiol, 109, 1, 10.1113/jphysiol.1949.sp004363 · DOI
  23. Rao, 2018, Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol HF, 6, 999
  24. Munoz-Canoves, 2013, Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?, FEBS J, 280, 4131, 10.1111/febs.12338 · DOI · Paper page
  25. Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, 101, 2461, 10.1182/blood-2002-10-3235 · DOI · Paper page
  26. Ridker, 2016, From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection, Circ Res, 118, 145, 10.1161/CIRCRESAHA.115.306656 · DOI · Paper page
  27. Van Tassell, 2014, Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study), Am J Cardiol, 113, 321, 10.1016/j.amjcard.2013.08.047 · DOI
  28. Van Tassell, 2018, IL-1 blockade in patients with heart failure with preserved ejection fraction, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005036 · DOI
  29. van Heerebeek, 2012, Low myocardial protein kinase G activity in heart failure with preserved ejection fraction, Circulation, 126, 830, 10.1161/CIRCULATIONAHA.111.076075 · DOI
  30. Obokata, 2022, Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity, Eur J Heart Fail, 24, 353, 10.1002/ejhf.2377 · DOI · Paper page
  31. Pandey, 2021, Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC State-of-the-Art Review, J Am Coll Cardiol, 78, 1166, 10.1016/j.jacc.2021.07.014 · DOI · Paper page
  32. Garbers, 2018, Interleukin-6: designing specific therapeutics for a complex cytokine, Nat Rev Drug Discov, 17, 395, 10.1038/nrd.2018.45 · DOI · Paper page
  33. Ridker, 2021, IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial, Lancet, 397, 2060, 10.1016/S0140-6736(21)00520-1 · DOI
  34. Fukuta, 2005, Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report, Circulation, 112, 357, 10.1161/CIRCULATIONAHA.104.519876 · DOI

Cited by

Sorted by citations

Metadata

Authors
Alogna, A., Koepp, K. E., Sabbah, M., Espindola Netto, J. M., Jensen, M. D., Kirkland, J. L., Lam, C. S. P., Obokata, M., Petrie, M. C., Ridker, P. M., Sorimachi, H., Tchkonia, T., Voors, A., Redfield, M. M., & Borlaug, B. A.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2023-11
Volume
11
Issue
11
Pages
1549-1561
ISSN
2213-1779
DOI
10.1016/j.jchf.2023.06.031
PMC
PMC10895473
Cited by
142
References
7
Language
en
Licence
Funders
NHLBI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review